Effects of aspartame metabolites on astrocytes and neurons.
Level 5 - mechanism / opinion, no new human data
Narrative review of proposed biological mechanisms without primary empirical data or systematic search methodology
PubMed 23553132 · doi:10.5114/fn.2013.34191
What was done
Narrative review evaluating the direct and indirect mechanisms by which aspartame breakdown products affect astrocytes and neurons in the central nervous system.
What was found
The abstract reports that aspartame degrades into phenylalanine (50%), aspartic acid (40%), and methanol (10%). It describes mechanisms wherein excess phenylalanine impairs amino acid transport and reduces dopamine and serotonin levels; excess aspartic acid promotes glutamate-related excitotoxicity and cellular degeneration; methanol causes CNS depression and metabolic acidosis; and the metabolite diketopiperazine is implicated in CNS tumor pathogenesis (including gliomas, medulloblastomas, and meningiomas). No primary empirical numbers, sample sizes, or effect estimates were reported.
Why it matters
Synthesizes proposed cellular pathways through which glial cells and aspartame metabolites may interact to influence neurotoxicity and CNS disease.
Limits
This is a non-systematic narrative review with no defined search criteria, study count, or quality appraisal. It reports theoretical and mechanistic claims without human dose-response thresholds, exposure levels, or clinical outcome data.
Cited by
- supports Aspartame is metabolized in the human body into phenylalanine, aspartate, and methanol.